CARGO Therapeutics, Inc. Common Stock
NAS:CRGXHealthcare——At close · Market cap —
| USD millions | FY2021 | FY2022 | FY2023 | FY2024 | Trend | YoY |
|---|---|---|---|---|---|---|
| Net income | (5.9) | (41.0) | (98.1) | (167.5) | −70.7% | |
| Depreciation & amortization | 0.1 | 1.4 | 3.7 | 7.1 | +91.6% | |
| Stock-based compensation | 0.5 | 0.3 | 3.3 | 18.0 | +440.2% | |
| Change in working capital | 0.3 | 3.0 | 2.2 | 5.8 | +161.4% | |
| Operating cash flow | (4.9) | (29.1) | (81.2) | (139.7) | −72.2% | |
| Capital expenditure | (0.4) | (3.3) | (9.0) | (4.4) | +50.5% | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Investing cash flow | (0.4) | (3.3) | (9.0) | (305.1) | −3292.8% | |
| Dividends paid | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Share buybacks | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Debt issued / repaid | 0.0 | 28.5 | 3.5 | 0.0 | −100.0% | |
| Financing cash flow | 5.4 | 34.2 | 494.6 | 103.5 | −79.1% | |
| Free cash flow | (5.4) | (32.4) | (90.2) | (144.2) | −59.9% | |
| Net change in cash | 0.0 | 1.8 | 404.4 | (341.4) | −184.4% |
USD millionsUpdated 8 May 2025 ·
ⓘ
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
